The Methods and Strategies to Improve the Stability of Nano Antibody
DOI:
https://doi.org/10.54097/c9fzt478Keywords:
Nano-Antibody; Stability; Structure; Sequence.Abstract
Because of the advantages of simple structure, easy modification, low immunogenicity, good stability, strong specificity and strong affinity, nano-antibodies have broad development space in clinical practice. Compared with traditional antibodies, nano antibodies are easier to store and transport, and after denaturation in high temperature, chemical, pressure and other environments, they can still be efficiently recombined, thereby regaining affinity for antigens. The structure and stability of nano antibody were studied. Multiple DNA sequence repair with the same sequence, easily modified amino acid replacement, protein net charge change, unnatural disulfide bond introduction and CDR supervariable region transfer was used to control the stability of the protein. The implementation of this project is expected to lay a foundation for improving its application in the fields of drug therapy, diagnosis and biosensing.
Downloads
References
Jia Haijing, GAO Yajing, Lou Xinhui. The main research directions, progress and challenges of aptamer screening and affinity evaluation technology. Advances in Biochemistry and Biophysics, Vol. 50 (2023) No.9, p.2051-2076.
Tong Ling, HUANG Guohui, Chen Shanshuang. Anti-gfp nanoantibodies for affinity ligand purification of gap junction protein 26. Biotechnology, Vol. 33 (2022) No.3, p.281-286.
Yan Wenlu, Lang Tianqun, Yin Qi, et al. Progress in improving tumor immunotherapy by actively targeting nanodrug delivery systems. Acta Pharmacologica Sinica, Vol. 57 (2022) No.1, p.208-214.
Wang Yuxuan, Liu Lin, Liu Mingfei, et al. Preparation of GDF15 fusion protein and its application in non-alcoholic steatohepatitis. Chinese Journal of Hospital Pharmacy, Vol. 43 (2023) No.3, p.2659-2665.
Guo Shujing, WANG Xuede, Hu Yuyuan, et al. Advances in lipid based nanoparticles and their use as delivery carriers for phytosterols. Journal of Henan University of Technology Natural Science Edition, Vol. 44 (2021) No.6, p.123-129.
Ren Junwen, Jiang Guoqing, Chen Zhijie, et al. Surface structure design of boron nitride nanotubes and its mechanism of regulating the properties of epoxy composite dielectric. Acta Physica Sinica, Vol. 73 (2022) No.2, p.02-08.
Lv Jingwen. Reliability assignment based on Pythagorean Hesitancy Fuzzy. Operations Research and Fuzzy Science, Vol. 13 (2022) No.6, p.106-114.
Tang Chunxia, Li Meng, Wang Yuxi, etal. Progress in structural design of functionalized cellulose nanomaterials for Cr(Ⅵ) removal. Advances in Chemical Engineering, Vol. 42 (2022) No.2, p.585-594.
Liu Yong, Xu Zhewei, Wang Mingwei, et al. Design and properties of porous platinum-based alloy nanoelectrocatalytic materials. Science and Technology Achievements in China, Vol. 24 (2023) No.6, p.4-8.
Kuang H Y, Chen C. Research progress in the design, synthesis and electrocatalytic performance of precious metal nanoframes. Journal of Chemistry of Chinese Universities, Vol. 23, 44 (2022) No.1, p.202-209.
Yang Qhua, Liu Yuheng, Zhang Dandan, etal. Study on respiratory mucosal mRNA vaccine based on polypeptides-poloxamide nanoparticle carrier. Journal of Army Medical University, Vol. 45 (2023) No.3, p.1377-1387.
Bao Wen, Liu Ran, Wang Fei, et al. Basic study of transferritin receptor monoclonal antibody nanoparticle drug delivery system in the treatment of leukemia. Chinese Journal of Experimental Hematology, Vol.31 (2022) No.4):939-944.
Hu Xiangyun, Cao Yan-Hong, LV Lingyan, et al. Nano-antibody and its research status in veterinary field. Journal of Animal Science and Veterinary Medicine, Vol.54 (2022) No.8):3164-3172.
Wu Yue, Sun Baihe, ZHAO Rui, et al. Research progress of therapeutic nanoantibodies in different drug delivery routes. Chinese Journal of Bioengineering, Vol.43 (2023) No.1):120-126.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Academic Journal of Science and Technology

This work is licensed under a Creative Commons Attribution 4.0 International License.








